Luxembourg Partners with U.S. Firms for $200M Molecular Med Investment
On June 5, 2008, the government of the Grand Duchy of Luxembourg announced plans for a $200 million five-year molecular medicine initiative that draws on a strategic partnership involving three Luxembourg Public Research Centers (CRPs), the University of Luxembourg and three U.S. research institutes prominent in the field.
The U.S. research institutions include:
- Translational Genomics Research Institute (TGen) in Phoenix, led by Dr. Jeffrey Trent;